ALLN rescues an in vitro excitatory synaptic transmission deficit in Lis1 mutant mice

Journal of Neurophysiology

Volumn 109, Issue 2, 2013, Pages 429-436

  Sebe, Joy Y ^a   Bershteyn, Marina ^a   Hirotsune, Shinji ^b   Wynshaw Boris, Anthony ^a   Baraban, Scott C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

ALLN; Cortical malformation; Epilepsy; Lissencephaly; Treatment

Indexed keywords

CALPASTATIN; FODRIN;

AGYRIA; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; FEMALE; GENE; HIPPOCAMPUS; IN VITRO STUDY; MALE; MOUSE; NERVE CELL STIMULATION; NEUROPROTECTION; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; SYNAPTIC TRANSMISSION; WESTERN BLOTTING;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ANIMALS; CALPAIN; CYSTEINE PROTEINASE INHIBITORS; EXCITATORY POSTSYNAPTIC POTENTIALS; GENE EXPRESSION; HETEROZYGOTE; LEUPEPTINS; LISSENCEPHALY; MICE; MICE, MUTANT STRAINS; MICROTUBULE-ASSOCIATED PROTEINS; MINIATURE POSTSYNAPTIC POTENTIALS; MUTATION; PROTEOLYSIS; PYRAMIDAL CELLS; SPECTRIN;

EID: 84872414208     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.00431.2012     Document Type: Article

References (45)

1. Ando K, Kudo Y, Takahashi M. Negative regulation of neurotransmitter release by calpain: a possible involvement of specific SNAP-25 cleavage. J Neurochem 94: 651-658, 2005.
2. Augustin I, Rosenmund C, Sudhof TC, Brose N. Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles. Nature 400: 457-461, 1999.
3. Bi X, Tocco G, Baudry M. Calpain-mediated regulation of AMPA receptors in adult rat brain. Neuroreport 6: 61-64, 1994.
4. Brodtkorb E, Nilsen G, Smevik O, Rinck PA. Epilepsy and anomalies of neuronal migration: MRI and clinical aspects. Acta Neurol Scand 86: 24-32, 1992.
5. Buddhala C, Suarez M, Modi J, Prentice H, Ma Z, Tao R, Wu JY. Calpain cleavage of brain glutamic acid decarboxylase 65 is pathological and impairs GABA neurotransmission. PLoS One 7: e33002, 2012.
6. Crocker SJ, Smith PD, Jackson-Lewis V, Lamba WR, Hayley SP, Grimm E, Callaghan SM, Slack RS, Melloni E, Przedborski S, Robertson GS, Anisman H, Merali Z, Park DS. Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. J Neurosci 23: 4081-4091, 2003.
7. Dobyns WB. The clinical patterns and molecular genetics of lissencephaly and subcortical band heterotopia. Epilepsia 51, Suppl 1: 5-9, 2010.
8. Dobyns WB, Reiner O, Carrozzo R, Ledbetter DH. Lissencephaly. A human brain malformation associated with deletion of the LIS1 gene located at chromosome 17p13. JAMA 270: 2838-2842, 1993.
9. Fleck MW, Hirotsune S, Gambello MJ, Phillips-Tansey E, Suares G, Mervis RF, Wynshaw-Boris A, McBain CJ. Hippocampal abnormalities and enhanced excitability in a murine model of human lissencephaly. J Neurosci 20: 2439-2450, 2000.
10. Franco SJ, Huttenlocher A. Regulating cell migration: calpains make the cut. J Cell Sci 118: 3829-3838, 2005.
11. Fritschy JM, Harvey RJ, Schwarz G. Gephyrin: where do we stand, where do we go? Trends Neurosci 31: 257-264, 2008.
12. Goll DE, Thompson VF, Li H, Wei W, Cong J. The calpain system. Physiol Rev 83: 731-801, 2003.
13. Greenwood JS, Wang Y, Estrada RC, Ackerman L, Ohara PT, Baraban SC. Seizures, enhanced excitation, and increased vesicle number in Lis1 mutant mice. Ann Neurol 66: 644-653, 2009.
14. Grumelli C, Berghuis P, Pozzi D, Caleo M, Antonucci F, Bonanno G, Carmignoto G, Dobszay MB, Harkany T, Matteoli M, Verderio C. Calpain activity contributes to the control of SNAP-25 levels in neurons. Mol Cell Neurosci 39: 314-323, 2008.
15. Guttmann RP, Baker DL, Seifert KM, Cohen AS, Coulter DA, Lynch DR. Specific proteolysis of the NR2 subunit at multiple sites by calpain. J Neurochem 78: 1083-1093, 2001.
16. Hardiman O, Burke T, Phillips J, Murphy S, O'Moore B, Staunton H, Farrell MA. Microdysgenesis in resected temporal neocortex: incidence and clinical significance in focal epilepsy. Neurology 38: 1041-1047, 1988.
17. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 34: 453-468, 1993.
18. Hellwig S, Hack I, Kowalski J, Brunne B, Jarowyj J, Unger A, Bock HH, Junghans D, Frotscher M. Role for Reelin in neurotransmitter release. J Neurosci 31: 2352-2360, 2011.
19. Hirotsune S, Fleck MW, Gambello MJ, Bix GJ, Chen A, Clark GD, Ledbetter DH, McBain CJ, Wynshaw-Boris A. Graded reduction of Pafah1b1 (Lis1) activity results in neuronal migration defects and early embryonic lethality. Nat Genet 19: 333-339, 1998.
20. Hong SE, Shugart YY, Huang DT, Shahwan SA, Grant PE, Hourihane JO, Martin ND, Walsh CA. Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations. Nat Genet 26: 93-96, 2000.
21. Jones DL, Baraban SC. Characterization of inhibitory circuits in the malformed hippocampus of Lis1 mutant mice. J Neurophysiol 98: 2737-2746, 2007.
22. Kato M, Dobyns WB. Lissencephaly and the molecular basis of neuronal migration. Hum Mol Genet 12: R89-R96, 2003.
23. Kim E, Sheng M. PDZ domain proteins of synapses. Nat Rev Neurosci 5: 771-781, 2004.
24. Liu J, Liu MC, Wang KK. Calpain in the CNS: from synaptic function to neurotoxicity. Sci Signal 1: re1, 2008.
25. Nowak L, Bregestovski P, Ascher P, Herbet A, Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurones. Nature 307: 462-465, 1984.
26. Patrylo PR, Browning RA, Cranick S. Reeler homozygous mice exhibit enhanced susceptibility to epileptiform activity. Epilepsia 47: 257-266, 2006.
27. Paylor R, Hirotsune S, Gambello MJ, Yuva-Paylor L, Crawley JN, Wynshaw-Boris A. Impaired learning and motor behavior in heterozygous Pafah1b1 (Lis1) mutant mice. Learn Mem 6: 521-537, 1999.
28. Raynaud F, Marcilhac A. Implication of calpain in neuronal apoptosis. A possible regulation of Alzheimer's disease. FEBS J 273: 3437-3443, 2006.
29. Saatman KE, Creed J, Raghupathi R. Calpain as a therapeutic target in traumatic brain injury. Neurotherapeutics 7: 31-42, 2010.
30. Saito K, Elce JS, Hamos JE, Nixon RA. Widespread activation of calciumactivated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci USA 90: 2628-2632, 1993.
31. Santella L, Kyozuka K, De Riso L, Carafoli E. Calcium, protease action, and the regulation of the cell cycle. Cell Calcium 23: 123-130, 1998.
32. Shimizu K, Phan T, Mansuy IM, Storm DR. Proteolytic degradation of SCOP in the hippocampus contributes to activation of MAP kinase and memory. Cell 128: 1219-1229, 2007.
33. Shu T, Ayala R, Nguyen MD, Xie Z, Gleeson JG, Tsai LH. Ndel1 operates in a common pathway with LIS1 and cytoplasmic dynein to regulate cortical neuronal positioning. Neuron 44: 263-277, 2004.
34. Varoqueaux F, Aramuni G, Rawson RL, Mohrmann R, Missler M, Gottmann K, Zhang W, Sudhof TC, Brose N. Neuroligins determine synapse maturation and function. Neuron 51: 741-754, 2006.
35. Varoqueaux F, Jamain S, Brose N. Neuroligin 2 is exclusively localized to inhibitory synapses. Eur J Cell Biol 83: 449-456, 2004.
36. Varoqueaux F, Sigler A, Rhee JS, Brose N, Enk C, Reim K, Rosenmund C. Total arrest of spontaneous and evoked synaptic transmission but normal synaptogenesis in the absence of Munc13-mediated vesicle priming. Proc Natl Acad Sci USA 99: 9037-9042, 2002.
37. Verderio C, Pozzi D, Pravettoni E, Inverardi F, Schenk U, Coco S, Proux-Gillardeaux V, Galli T, Rossetto O, Frassoni C, Matteoli M. SNAP-25 modulation of calcium dynamics underlies differences in GABAergic and glutamatergic responsiveness to depolarization. Neuron 41: 599-610, 2004.
38. Wang Y, Baraban SC. Aberrant dentate gyrus cytoarchitecture and fiber lamination in Lis1 mutant mice. Hippocampus 18: 758-765, 2008.
39. Wang Y, Greenwood JS, Calcagnotto ME, Kirsch HE, Barbaro NM, Baraban SC. Neocortical hyperexcitability in a human case of tuberous sclerosis complex and mice lacking neuronal expression of TSC1. Ann Neurol 61: 139-152, 2007.
40. Yamada M, Toba S, Yoshida Y, Haratani K, Mori D, Yano Y, Mimori-Kiyosue Y, Nakamura T, Itoh K, Fushiki S, Setou M, Wynshaw-Boris A, Torisawa T, Toyoshima YY, Hirotsune S. LIS1 and NDEL1 coordinate the plus-end-directed transport of cytoplasmic dynein. EMBO J 27: 2471-2483, 2008.
41. Yamada M, Yoshida Y, Mori D, Takitoh T, Kengaku M, Umeshima H, Takao K, Miyakawa T, Sato M, Sorimachi H, Wynshaw-Boris A, Hirotsune S. Inhibition of calpain increases LIS1 expression and partially rescues in vivo phenotypes in a mouse model of lissencephaly. Nat Med 15: 1202-1207, 2009.
42. Yingling J, Youn YH, Darling D, Toyo-Oka K, Pramparo T, Hirotsune S, Wynshaw-Boris A. Neuroepithelial stem cell proliferation requires LIS1 for precise spindle orientation and symmetric division. Cell 132: 474-486, 2008.
43. Yuen EY, Gu Z, Yan Z. Calpain regulation of AMPA receptor channels in cortical pyramidal neurons. J Physiol 580: 241-254, 2007.
44. Yuen EY, Ren Y, Yan Z. Postsynaptic density-95 (PSD-95) and calcineurin control the sensitivity of N-methyl-D-aspartate receptors to calpain cleavage in cortical neurons. Mol Pharmacol 74: 360-370, 2008.
45. Zadran S, Bi X, Baudry M. Regulation of calpain-2 in neurons: implications for synaptic plasticity. Mol Neurobiol 42: 143-150, 2010.